tirzepatide news - Search News

FDA, Tirzepatide

INSIDER on MSN · 3d

The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.

FOX News on MSN · 2d

FDA approves first medication for obstructive sleep apnea — which also promotes weight loss

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period

The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put a stop to companies making cheaper copies.

The American Journal of Manage… · 7d

Weight Loss Drug Tirzepatide Now Approved for Sleep Apnea in Adults With Obesity

The approval was based on the results of the SURMOUNT-OSA trial, which found patients had fewer breathing disruptions.

The Indian Express · 2d

US FDA approves use of weight loss drug for sleep apnoea: Here’s all you need to know

The drug has been approved for use in combination with a low-calorie diet and increased physical activity in those with moderate to severe OSA. This shows that the weight-loss drug has multifarious uses other than controlling type-2 diabetes and obesity.

1don MSN

The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using an Off-Brand Version

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...

Everyday Health3h

FDA Approves First Medication for Obstructive Sleep Apnea

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

AOL19h

What is Compounded Tirzepatide? Here's What You Need to Know

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you’re starting a weight loss journey, you might have ...

3don MSN

FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

MedPage Today7d

FDA Says Compounded Tirzepatide Must Exit the Market

Approved in 2022 for type 2 diabetes and in 2023 for chronic weight management along with diet and exercise, tirzepatide is ...

Psychology Today10h

GLP-1RAs in People With Higher Weight and Eating Disorders

GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 501.82% and ...

15h

From Hollywood's best-kept secret to affordable weight loss for all

GLP-1 medications like Semaglutide (found in Ozempic and Wegovy) and Tirzepatide (found in Mounjaro) mimic the body’s natural ...

Flow Space on MSN11h

Semaglutide Is Not the Best GLP-1 Drug You Can Take for Losing Weight Fast

Tirzepatide may be more effective than semaglutide in helping people lose weight. At least that's the findings from recent ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results